Annual CFF
$659.51 M
+$650.60 M+7300.21%
December 31, 2024
Summary
- As of March 12, 2025, NAMS annual cash flow from financing activities is $659.51 million, with the most recent change of +$650.60 million (+7300.21%) on December 31, 2024.
- During the last 3 years, NAMS annual CFF has risen by +$574.80 million (+678.60%).
- NAMS annual CFF is now at all-time high.
Performance
NAMS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$456.61 M
+$456.55 M+787160.34%
December 31, 2024
Summary
- As of March 12, 2025, NAMS quarterly cash flow from financing activities is $456.61 million, with the most recent change of +$456.55 million (+787160.34%) on December 31, 2024.
- Over the past year, NAMS quarterly CFF has increased by +$456.55 million (+787160.34%).
- NAMS quarterly CFF is now at all-time high.
Performance
NAMS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$659.51 M
+$456.61 M+225.05%
December 31, 2024
Summary
- As of March 12, 2025, NAMS TTM cash flow from financing activities is $659.51 million, with the most recent change of +$456.61 million (+225.05%) on December 31, 2024.
- Over the past year, NAMS TTM CFF has increased by +$456.61 million (+225.05%).
- NAMS TTM CFF is now at all-time high.
Performance
NAMS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NAMS Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7300.2% | +10000.0% | +225.1% |
| 3 y3 years | +678.6% | +10000.0% | +225.1% |
| 5 y5 years | +4636.8% | +10000.0% | +225.1% |
NAMS Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7300.2% | at high | -100.0% | at high | >+9999.0% |
| 5 y | 5-year | at high | +7300.2% | at high | -100.0% | at high | >+9999.0% |
| alltime | all time | at high | +7300.2% | at high | -100.0% | at high | >+9999.0% |
NewAmsterdam Pharma Company NV Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $659.51 M(+7300.2%) | $456.61 M(>+9900.0%) | $659.51 M(+225.0%) |
| Sep 2024 | - | $58.00 K(-98.8%) | $202.90 M(-0.1%) |
| Jun 2024 | - | $4.66 M(-97.6%) | $203.02 M(-0.8%) |
| Mar 2024 | - | $198.18 M(>+9900.0%) | $204.70 M(+2196.9%) |
| Dec 2023 | $8.91 M | $0.00(-100.0%) | $8.91 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $186.00 K(-97.1%) | $8.91 M(+2.1%) |
| Jun 2023 | - | $6.33 M(+164.8%) | $8.73 M(+264.8%) |
| Mar 2023 | - | $2.39 M | $2.39 M |
| Dec 2022 | $391.90 M(+362.7%) | - | - |
| Dec 2021 | $84.70 M(+508.4%) | - | - |
| Dec 2020 | $13.92 M | - | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual cash flow from financing activities?
- What is the all time high annual CFF for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual CFF year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly CFF year-on-year change?
- What is NewAmsterdam Pharma Company NV TTM cash flow from financing activities?
- What is the all time high TTM CFF for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV TTM CFF year-on-year change?
What is NewAmsterdam Pharma Company NV annual cash flow from financing activities?
The current annual CFF of NAMS is $659.51 M
What is the all time high annual CFF for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual cash flow from financing activities is $659.51 M
What is NewAmsterdam Pharma Company NV annual CFF year-on-year change?
Over the past year, NAMS annual cash flow from financing activities has changed by +$650.60 M (+7300.21%)
What is NewAmsterdam Pharma Company NV quarterly cash flow from financing activities?
The current quarterly CFF of NAMS is $456.61 M
What is the all time high quarterly CFF for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly cash flow from financing activities is $456.61 M
What is NewAmsterdam Pharma Company NV quarterly CFF year-on-year change?
Over the past year, NAMS quarterly cash flow from financing activities has changed by +$456.55 M (+787160.34%)
What is NewAmsterdam Pharma Company NV TTM cash flow from financing activities?
The current TTM CFF of NAMS is $659.51 M
What is the all time high TTM CFF for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high TTM cash flow from financing activities is $659.51 M
What is NewAmsterdam Pharma Company NV TTM CFF year-on-year change?
Over the past year, NAMS TTM cash flow from financing activities has changed by +$456.61 M (+225.05%)